Intimation Regarding Closure of Trading Window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has informed BSE that its trading window will remain closed starting Thursday, 1st January 2026. The closure will last until 48 hours after the company declares its unaudited financial results for the quarter ended 31st December 2025 (Q3 FY26). During this period, promoters, promoter group members, directors, key managerial personnel, designated persons, and their immediate relatives are prohibited from trading in the company's securities. The Board meeting date to approve these quarterly results will be communicated separately in due course. This is a routine compliance filing under SEBI's Insider Trading Regulations.
No direct impact on shareholders or stock price. This is a standard regulatory disclosure indicating that upcoming Q3 FY26 results are expected in the coming weeks, which investors should watch for.